scholarly article | Q13442814 |
P356 | DOI | 10.1002/ANIE.201309301 |
P698 | PubMed publication ID | 24458566 |
P50 | author | Rainer E Martin | Q87506723 |
P2093 | author name string | Horst Vogel | |
Alexander I Alanine | |||
Christoph Kuratli | |||
David Wechsler | |||
Michael Werner | |||
Remo Hochstrasser | |||
Thilo Enderle | |||
P2860 | cites work | Flow chemistry synthesis of zolpidem, alpidem and other GABAAagonists and their biological evaluation through the use of in-line frontal affinity chromatography | Q56951708 |
The flow synthesis of heterocycles for natural product and medicinal chemistry applications | Q56951891 | ||
β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer’s Disease | Q27684422 | ||
Hit and lead generation: beyond high-throughput screening | Q28204526 | ||
Micro Total Analysis Systems: Fundamental Advances and Applications in the Laboratory, Clinic, and Field | Q30444364 | ||
Micro Total Analysis Systems for Cell Biology and Biochemical Assays | Q30459045 | ||
Substrate and Inhibitor Profile of BACE (β-Secretase) and Comparison with Other Mammalian Aspartic Proteases | Q31032457 | ||
High-resolution dose-response screening using droplet-based microfluidics | Q34112944 | ||
Micro- and nanofluidic systems for high-throughput biological screening | Q37317318 | ||
Microfluidic devices for bioapplications | Q37809013 | ||
Continuous-flow organic synthesis: a tool for the modern medicinal chemist | Q37855814 | ||
The productivity crisis in pharmaceutical R&D. | Q37883027 | ||
Continuous Flow Synthesis. A Pharma Perspective | Q37979238 | ||
Revisiting lab-on-a-chip technology for drug discovery. | Q38031120 | ||
Novel Process Windows for Enabling, Accelerating, and Uplifting Flow Chemistry | Q38100756 | ||
Integrated Synthesis and Testing of Substituted Xanthine Based DPP4 Inhibitors: Application to Drug Discovery | Q39771545 | ||
Microfluidic gradient-generating device for pharmacological profiling | Q40403674 | ||
Rapid discovery of a novel series of Abl kinase inhibitors by application of an integrated microfluidic synthesis and screening platform. | Q42712714 | ||
Characterization of sensitivity and specificity in leaky droplet-based assays | Q51536122 | ||
Droplet-based microfluidic flow injection system with large-scale concentration gradient by a single nanoliter-scale injection for enzyme inhibition assay | Q51544050 | ||
Dispersion of Soluble Matter in Solvent Flowing Slowly through a Tube | Q56553507 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1704-1708 | |
P577 | publication date | 2014-01-23 | |
P1433 | published in | Angewandte Chemie International Edition | Q62023953 |
P1476 | title | Seamless integration of dose-response screening and flow chemistry: efficient generation of structure-activity relationship data of β-secretase (BACE1) inhibitors | |
P478 | volume | 53 |
Q38209736 | Accessing new chemical entities through microfluidic systems |
Q47780833 | Automating drug discovery |
Q53920769 | CHEMICAL SYNTHESIS. Going with the flow. |
Q28066266 | Current status and future prospects for enabling chemistry technology in the drug discovery process |
Q93166887 | Exploiting Chemical Toolboxes for the Expedited Generation of Tetracyclic Quinolines as a Novel Class of PXR Agonists |
Q36354649 | Integrated Platform for Expedited Synthesis-Purification-Testing of Small Molecule Libraries |
Q52311748 | Nanoscale synthesis and affinity ranking |
Q39140639 | Recent lab-on-chip developments for novel drug discovery |
Q36520996 | Screening applications in drug discovery based on microfluidic technology. |
Q59883083 | Streamlining bioactive molecular discovery through integration and automation |
Search more.